The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer

OBJECTIVE: To assess the prognostic value of the systemic immune-inflammation index (SII) in patients with vulvar cancer. METHODS: Data of 130 consecutive patients who underwent primary surgical resection for vulvar cancer at the Medical University of Vienna between 1999 and 2018 was retrospectively...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gynecol Oncol
Hlavní autoři: Bartl, Thomas, Bekos, Christine, Postl, Magdalena, Alexander, Reinthaller, Polterauer, Stephan, Stefanie, Aust, Richard, Schwameis
Médium: Artigo
Jazyk:Inglês
Vydáno: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767659/
https://ncbi.nlm.nih.gov/pubmed/33185042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky